Early Feeding for Gastroschisis
(GAIN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the safety and effectiveness of early feeding in babies born with gastroschisis, a condition where the intestines are outside the body at birth. The trial aims to determine if feeding human milk soon after surgery aids recovery. It focuses on babies born at least 34 weeks into pregnancy who are stable post-surgery. This trial targets infants without other major health complications. As an unphased trial, it provides a unique opportunity to contribute to understanding how early feeding can aid recovery in infants with gastroschisis.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that the Early Feeding Protocol is safe for neonates with gastroschisis?
Research has shown that early feeding for infants with gastroschisis can be safe. One study found that increasing food by 20 mL per kilogram of the baby's weight each day helped them reach feeding goals faster and reduced hospital stays. This indicates the feeding method was well-tolerated. Another source suggests that increasing feeds by 12–30 mL per kilogram every 24–48 hours might improve feed tolerance and lower the risk of complications. While the trial continues to investigate serious side effects, current evidence supports the safety of early feeding in these infants.12345
Why are researchers excited about this trial?
Researchers are excited about the Early Feeding Protocol for gastroschisis because it aims to kickstart a newborn's feeding process much faster than traditional methods. Typically, babies with gastroschisis are fed intravenously while their intestines recover, which can delay oral feeding for weeks. However, this new protocol introduces human milk feeds within just 48 hours of surgery, potentially speeding up recovery and promoting oral motor skill development. By advancing feeds based on tolerance and clinical assessment, the protocol could significantly reduce hospital stays and improve outcomes for these vulnerable infants.
What evidence suggests that this early feeding protocol is effective for gastroschisis?
Research has shown that a set feeding plan for infants with gastroschisis can be beneficial. In this trial, participants in the Early Feeding Protocol Group will follow a specific plan to begin human milk feeds within 48 hours of surgical repair. Studies have found that such plans enable babies to start feeding by mouth about three days earlier than those without a set plan. This method also helps develop essential feeding skills. Initiating feeds early with human milk soon after surgery aims to support growth and improve overall outcomes. Evidence suggests that early feeding can aid these infants in recovering and growing better post-surgery.26789
Who Is on the Research Team?
Nicole Cacho, DO
Principal Investigator
University of California, Davis
Geoanna Bautista, MD
Principal Investigator
University of California, Davis
Are You a Good Fit for This Trial?
This trial is for newborns with gastroschisis, where their intestines are outside the body at birth. The study will include those who meet specific health criteria set by the researchers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Neonates with gastroschisis undergo surgical repair and are initiated on early feeding protocol within 48 hours post-surgery
Follow-up
Participants are monitored for safety, growth parameters, and feeding progression after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Early Feeding Protocol
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
The Gerber Foundation
Collaborator
University of California Fetal Consortium
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator
University of California, Los Angeles
Collaborator